Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie’s disease

Abstract

Although the association between Peyronie’s disease (PD) and erectile dysfunction (ED) is well established, limited data are available correlating penile curvature and penile hemodynamic parameters. We sought to examine this association in a cohort of PD men undergoing penile duplex Doppler ultrasound (PDDU). PD patients were retrospectively evaluated to correlate the extent and direction of penile curvature with measured vascular parameters. Demographic variables, disease characteristics and PDDU parameters were tabulated and statistically compared based on extent (≤45° and >45°) and direction (dorsal, ventral, lateral, ventrolateral, dorsolateral) of curvature. A total of 220 PD patients (mean age of 55.0±9.2 years) underwent PDDU at one institution from January 2008 to December 2010. Overall, 69.5% of patients were found to have vasculogenic ED (arterial insufficiency (AI): 10%; veno-occlusive dysfunction (VOD): 43.2%; AI+VOD: 16.4%). Mean curvature was similar among all PDDU groups (AI: 41.7±5.2°; VOD: 41.3±2.5°; AI+VOD: 37±4.1°; no-ED: 37.3±3°; P>0.85). No significant differences were noted in the presence or type of ED among various directions of curvature (P=0.34) or when curvatures were stratified by ≤45° and >45°. The direction and extent of penile curvature are not associated with altered rates of vasculogenic ED on PDDU in PD patients.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E et al. Peyronie’s disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol 2001; 40: 525–530.

    Article  CAS  Google Scholar 

  2. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A et al. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol 2004; 171 (6 Pt 1): 2350–2353.

    Article  Google Scholar 

  3. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U . The prevalence of Peyronie’s disease: results of a large survey. BJU Int 2001; 88: 727–730.

    Article  CAS  Google Scholar 

  4. Smith JF, Walsh TJ, Lue TF . Peyronie’s disease: a critical appraisal of current diagnosis and treatment. Int J Impot Res 2008; 20: 445–459.

    Article  CAS  Google Scholar 

  5. Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M et al. The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med 2010; 7: 2359–2374.

    Article  Google Scholar 

  6. Chung E, De Young L, Brock GB . Penile duplex ultrasonography in men with Peyronie’s disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction? J Sex Med 2011; 8: 3446–3451.

    Article  Google Scholar 

  7. Gelbard MK, Dorey F, James K . The natural history of Peyronie’s disease. J Urol 1990; 144: 1376–1379.

    Article  CAS  Google Scholar 

  8. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S . A retrospective review of 307 men with Peyronie’s disease. J Urol 2002; 168: 1075–1079.

    Article  Google Scholar 

  9. Mulhall JP, Schiff J, Guhring P . An analysis of the natural history of Peyronie’s disease. J Urol 2006; 175: 2115–2118, discussion 2118.

    Article  Google Scholar 

  10. Amin Z, Patel U, Friedman EP, Vale JA, Kirby R, Lees WR . Colour Doppler and duplex ultrasound assessment of Peyronie’s disease in impotent men. Br J Radiol 1993; 66: 398–402.

    Article  CAS  Google Scholar 

  11. Kadioglu A, Oktar T, Kandirali E, Kendirci M, Sanli O, Ozsoy C . Incidentally diagnosed Peyronie’s disease in men presenting with erectile dysfunction. Int J Impot Res 2004; 16: 540–543.

    Article  CAS  Google Scholar 

  12. Grasso M, Lania C, Blanco S, Limonta G . The natural history of Peyronie’s disease. Arch Esp Urol 2007; 60: 326–331.

    Article  Google Scholar 

  13. Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT . The incidence of Peyronie’s disease in Rochester, Minnesota, 1950 through 1984. J Urol 1991; 146: 1007–1009.

    Article  CAS  Google Scholar 

  14. Gonzalez-Cadavid NF . Mechanisms of penile fibrosis. J Sex Med 2009; 6 (Suppl 3): 353–362.

    Article  Google Scholar 

  15. Bekos A, Arvaniti M, Hatzimouratidis K, Moysidis K, Tzortzis V, Hatzichristou D . The natural history of Peyronie's disease: an ultrasonography-based study. Eur Urol 2008; 53: 644–650.

    Article  Google Scholar 

  16. Walsh TJ, Hotaling JM, Lue TF, Smith JF . How curved is too curved? The severity of penile deformity may predict sexual disability among men with Peyronie's disease. Int J Impot Res 2013; 25: 109–112.

    Article  CAS  Google Scholar 

  17. Garaffa G, Trost LW, Serefoglu EC, Ralph D, Hellstrom WJ . Understanding the course of Peyronie’s disease. Int J Clin Pract 2013; 67: 781–788.

    Article  CAS  Google Scholar 

  18. Mulhall J, Anderson M, Parker M . A surgical algorithm for men with combined Peyronie’s disease and erectile dysfunction: functional and satisfaction outcomes. J Sex Med 2005; 2: 132–138.

    Article  Google Scholar 

  19. Serefoglu EC, Hellstrom WJ . Treatment of Peyronie’s disease: 2012 update. Curr Urol Rep 2011; 12: 444–452.

    Article  Google Scholar 

  20. Lee B, Sikka SC, Randrup ER, Villemarette P, Baum N, Hower JF et al. Standardization of penile blood flow parameters in normal men using intracavernous prostaglandin E1 and visual sexual stimulation. J Urol 1993; 149: 49–52.

    Article  CAS  Google Scholar 

  21. Kendirci M, Usta MF, Matern RV, Nowfar S, Sikka SC, Hellstrom WJ . The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease. J Sex Med 2005; 2: 709–715.

    Article  CAS  Google Scholar 

  22. Montorsi F, Guazzoni G, Bergamaschi F, Consonni P, Rigatti P, Pizzini G et al. Vascular abnormalities in Peyronie’s disease: the role of color Doppler sonography. J Urol 1994; 151: 373–375.

    Article  CAS  Google Scholar 

  23. Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X . A population-based study of Peyronie’s disease: prevalence and treatment patterns in the United States. Adv Urol 2011; 2011: 282503.

    Article  Google Scholar 

  24. Hellstrom WJ . Medical management of Peyronie’s disease. J Androl 2009; 30: 397–405.

    Article  CAS  Google Scholar 

  25. Chung E, Yan H, De Young L, Brock GB . Penile Doppler sonographic and clinical characteristics in Peyronie’s disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction. BJU Int 2012; 110: 1201–1205.

    Article  Google Scholar 

  26. Kadioglu A, Tefekli A, Erol H, Cayan S, Kandirali E . Color Doppler ultrasound assessment of penile vascular system in men with Peyronie’s disease. Int J Impot Res 2000; 12: 263–267.

    Article  CAS  Google Scholar 

  27. Bella AJ, Sener A, Foell K, Brock GB . Nonpalpable scarring of the penile septum as a cause of erectile dysfunction: an atypical form of Peyronie’s disease. J Sex Med 2007; 4: 226–230.

    Article  Google Scholar 

  28. Smith JF, Brant WO, Fradet V, Shindel AW, Vittinghoff E, Chi T et al. Penile sonographic and clinical characteristics in men with Peyronie’s disease. J Sex Med 2009; 6: 2858–2867.

    Article  Google Scholar 

  29. Breyer BN, Shindel AW, Huang YC, Eisenberg ML, Weiss DA, Lue TF et al. Are sonographic characteristics associated with progression to surgery in men with Peyronie’s disease? J Urol 2010; 183: 1484–1488.

    Article  Google Scholar 

  30. Deveci S, Palese M, Parker M, Guhring P, Mulhall JP . Erectile function profiles in men with Peyronie’s disease. J Urol 2006; 175: 1807–1811, discussion 1811.

    Article  Google Scholar 

  31. Usta MF, Bivalacqua TJ, Jabren GW, Myers L, Sanabria J, Sikka SC et al. Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie’s disease. J Urol 2004; 171 (2 Pt 1): 775–779.

    Article  Google Scholar 

  32. Usta MF, Bivalacqua TJ, Tokatli Z, Rivera F, Gulkesen KH, Sikka SC et al. Stratification of penile vascular pathologies in patients with Peyronie’s disease and in men with erectile dysfunction according to age: a comparative study. J Urol 2004; 172: 259–262.

    Article  Google Scholar 

  33. Kendirci M, Nowfar S, Gur S, Jabren GW, Sikka SC, Hellstrom WJ . The relationship between the type of penile abnormality and penile vascular status in patients with Peyronie’s disease. J Urol 2005; 174: 632–635, discussion 635.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W J G Hellstrom.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Serefoglu, E., Trost, L., Sikka, S. et al. The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie’s disease. Int J Impot Res 27, 6–8 (2015). https://doi.org/10.1038/ijir.2014.25

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2014.25

This article is cited by

Search

Quick links